<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>benzoxaborole methylamine pro-drugs is_metabolite_of benzaldehyde benzoxaborole intermediates — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>benzoxaborole methylamine pro-drugs</strong>
  <span class="pred">&mdash;is_metabolite_of&rarr;</span>
  <strong>benzaldehyde benzoxaborole intermediates</strong>
</div>
<div class="entity-id">UNKNOWN:benzoxaborole methylamine pro-drugs &nbsp;&middot;&nbsp; UNKNOWN:benzaldehyde benzoxaborole intermediates</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: DB Referenced (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 46.00<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (DB Referenced, 1 paper)<br>Score from 9 citations: <strong>46.00</strong><br><span style="color:#888">1&times; extends (+12.00) &middot; 2&times; supports (+20.00) &middot; 2&times; contradicts (-10.00) &middot; 4&times; applies (+24.00)</span><br>Neighbourhood: 50.39</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="DB Referenced"></span><span>DB Referenced</span><a href="https://doi.org/10.1371/journal.ppat.1006850">10.1371/journal.ppat.1006850</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 9 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:50px"></span><span>2</span><span class="cite-subtotal">&middot; +20.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CBP gene locus partial deletion — causes → AN11736 resistance in Trypanosoma congolense</span><span class="cite-claim-weight">+10.00</span><a href="../claim/dff49ffdf190402c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">genome-scale RNAi screen — distinguishes → CBP loss-of-function as primary resistance mechanism</span><span class="cite-claim-weight">+10.00</span><a href="../claim/7e80edd6c65f8baf.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:50px"></span><span>2</span><span class="cite-subtotal">&middot; -10.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CBP loss-of-function — decreases → net uptake of AN11736</span><span class="cite-claim-weight">-5.00</span><a href="../claim/9591351f50271ef7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">AN11736 — treats → Nagana (African Animal Trypanosomiasis)</span><span class="cite-claim-weight">-5.00</span><a href="../claim/43d8c62cf4b7d827.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:25px"></span><span>1</span><span class="cite-subtotal">&middot; +12.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">AN11736 — is_metabolite_of → benzoxaborole prodrug</span><span class="cite-claim-weight">+12.00</span><a href="../claim/129d8c9788dbcf44.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:100px"></span><span>4</span><span class="cite-subtotal">&middot; +24.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">trypanosome serine carboxypeptidases (CBPs) — activates → AN11736</span><span class="cite-claim-weight">+6.00</span><a href="../claim/3fdd6cc80c32c59e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CBP gene locus partial deletion — causes → AN11736 resistance in Trypanosoma brucei</span><span class="cite-claim-weight">+6.00</span><a href="../claim/c3424e0fb3082e8a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CBP re-expression — treats → AN11736 resistance in Trypanosoma brucei</span><span class="cite-claim-weight">+6.00</span><a href="../claim/0fc8d21a50c32e17.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CBP re-expression — treats → AN11736 resistance in Trypanosoma congolense</span><span class="cite-claim-weight">+6.00</span><a href="../claim/117be7ea60d9595f.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>bfd1af77b001ddb5</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:benzoxaborole methylamine pro-drugs">UNKNOWN:benzoxaborole methylamine pro-drugs</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/UNKNOWN:benzaldehyde benzoxaborole intermediates">UNKNOWN:benzaldehyde benzoxaborole intermediates</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
